Ikarian Capital’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-253,754
| Closed | -$1.09M | – | 160 |
|
|
2025
Q1 | $1.09M | Hold |
253,754
| – | – | 0.13% | 59 |
|
|
2024
Q4 | $2.18M | Buy |
253,754
+151,187
| +147% | +$1.3M | 0.3% | 43 |
|
|
2024
Q3 | $1.74M | Buy |
+102,567
| New | +$1.74M | 0.24% | 41 |
|
|
2024
Q1 | – | Sell |
-42,130
| Closed | -$674K | – | 121 |
|
|
2023
Q4 | $674K | Buy |
+42,130
| New | +$674K | 0.06% | 57 |
|
|
2023
Q3 | – | Sell |
-15,582
| Closed | -$1.02M | – | 122 |
|
|
2023
Q2 | $1.02M | Hold |
15,582
| – | – | 0.16% | 45 |
|
|
2023
Q1 | $932K | Hold |
15,582
| – | – | 0.21% | 60 |
|
|
2022
Q4 | $363K | Hold |
15,582
| – | – | 0.09% | 47 |
|
|
2022
Q3 | $521K | Sell |
15,582
-2,978
| -16% | -$99.6K | 0.1% | 48 |
|
|
2022
Q2 | $491K | Hold |
18,560
| – | – | 0.09% | 67 |
|
|
2022
Q1 | $546K | Buy |
18,560
+1,060
| +6% | +$31.2K | 0.07% | 95 |
|
|
2021
Q4 | $1.5M | Hold |
17,500
| – | – | 0.22% | 54 |
|
|
2021
Q3 | $1.3M | Buy |
+17,500
| New | +$1.3M | 0.09% | 86 |
|